British American Tobacco's failure in Turkey
Related Experiment Video
Updated: Jun 29, 2026
Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
1Royal Holloway, University of London, Egham Hill, Egham, TW20, 0EX, UK. s.lawrence@rhul.ac.uk.
Background And Objectives:
Transnational tobacco companies (TTCs) considered Turkey an important, potential investment market because of its high consumption rates and domestic commitment to tobacco. This paper outlines how British American Tobacco (BAT) attempted to establish a joint venture with the government monopoly TEKEL, while waiting for privatisation and a private tender.
Methods:
Analysis of tobacco industry documents from the Guildford Depository and online tobacco document sources.
Results:
BAT failed to establish a market share in Turkey until 2000 despite repeated attempts to form a joint venture with Turkey's tobacco monopoly, TEKEL, once the market liberalised in the mid 1980s.
Conclusions:
BAT's failure in the Turkish market was due to a misguided investment strategy focused solely on acquiring TEKEL and is contrasted with Philip Morris success in Turkey despite both TTCs working within Turkey's unstable and corrupt investing climate.
Related Concept Videos
01:23Tuberculosis
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:56Ethics in Research